AG001741

122320-73-4 | 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione

AG001741

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	122320-73-4
Catalog Number	AG001741(AGN-PC-0PG2GS)
Chemical Name	5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione
EC Number	431-390-4
IUPAC Name	5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
InChI	InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)
InChI Key	YASAKCUCGLMORW-UHFFFAOYSA-N
MDL Number	MFCD00871760
Molecular Formula	C18H19N3O3S
Molecular Weight	357.4268
NSC Number	758698
SMILES	CN(C1=NC=CC=C1)CCOC1=CC=C(CC2C(NC(S2)=O)=O)C=C1
Synonyms	5-((4-(2-methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate, Avandia, BRL 49653, BRL-49653, BRL49653, rosiglitazone, rosiglitazone maleate, rosiglitazone, 122320-73-4, Avandia, 5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione, Brl-49653, Rosiglizole, Rosiglitazone maleate, Brl 49653, rosiglitazone (Avandia), BRL49653, rosiglitazona, rosiglitazonum, Avandaryl, TDZ 01, Rosiglitazone [INN:BAN], Avandamet, CHEBI:50122, Rosigilitazone, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate, C18H19N3O3S, YASAKCUCGLMORW-UHFFFAOYSA-N, 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-, MFCD00871760, NCGC00095124-01, AK-72839, 5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione, DSSTox_CID_17131, DSSTox_RID_79303, DSSTox_GSID_37131, Q-201681, 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, 2,4-thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]-phenyl]methyl]-2,4-thiazolidine-dione, CAS-122320-73-4, SR-01000763023, Rosiglitazon, Rezult, Rosi, HSDB 7555, Rosiglitazone base, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione, 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione, 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione, 5-[4-[2-[N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, Rosigliazone maleate, Gaudil (TN), Rosiglitazone-Avandia, Rosiglitazone (INN), Spectrum_001703, 155141-29-0, Spectrum2_001241, Spectrum3_000997, Spectrum4_001125, Spectrum5_001464, Avandia;BRL-49653, AC1L2U9N, SCHEMBL5169, BSPBio_002693, KBioGR_001609, KBioSS_002183, KSC914G9L, SPECTRUM1504263, SPBio_001142, GTPL1056, DTXSID7037131, SCHEMBL14383595, CTK8B4395, KBio2_002183, KBio2_004751, KBio2_007319, KBio3_001913, KS-00000IPU, Rosiglitazone, >=98% (HPLC), HMS1922J11, HMS2094O13, HMS3649G08, HMS3656K16, Pharmakon1600-01504263, ACT04332, BCP03047, Tox21_111434, ANW-44906, BBL029079, BDBM50030474, BG0432, CCG-39102, GP6434, NSC758698, STL350047, AKOS015894872, Tox21_111434_1, AC-3459, API0006964, BCP9000017, CS-1088, DB00412, MCULE-8293284864, MP-0331, NSC-758698, RTC-064102, SB17326, VA11695, 2,4-Thiazolidinedione, 5-004-02-((((methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-, NCGC00095124-02, NCGC00095124-03, NCGC00095124-04, NCGC00095124-05, NCGC00095124-06, NCGC00095124-08, 4CA-1110, AN-12970, BR-72839, CC-34292, HY-17386, SC-19017, BCP0726000232, AB0011992, AB2000652, AX8017813, LS-151340, FT-0602578, R0106, S2556, ST24029274, SW197573-6, 20R734, 6P-065, D08491, J10213, S00306, AB00698473-15, AB00698473-17, AB00698473-18, AB00698473-19, AB00698473_20, AB00698473_21, AB00698473_22, AB00698473_23, C-20817, I06-0141, SR-01000763023-5, SR-01000763023-6, BRD-A97437073-001-02-3, BRD-A97437073-001-03-1, BRD-A97437073-001-04-9, SR-01000763023-12, (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion, 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4dione, 5-[4-[2-[Methyl(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione, IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin), (+/-)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione, 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI), 5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione, 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-2,4-thiazolidinedione, 5-[[4-[2-(methyl-pyridin-2-ylamino)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione, 5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione, 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione, 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]phenyl methyl]thiazolidine-2,4-dione, ROSIGLITAZONE HCl, UNII-05V02F2KDG, Rosiglitazone hydrochloride, CHEMBL121, 05V02F2KDG, CID77999, C18-H19-N3-O3-S, ACN-034462, CS-O-02247, 2255B, A4304, C089730, D000077154, 5-(4-[2-(METHYL-PYRIDIN-2-YL-AMINO)-ETHOXY]-BENZYL)-THIAZOLIDINE-2,4-DIONE, 5-[4-[2-[N-methyl-N-(2-pyridinyl)amino]ethoxy]benzyl]-2,4-thiazolidinedione, RGZ, RSG,

Complexity	469
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	357.115g/mol
Formal Charge	0
Heavy Atom Count	25
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	357.428g/mol
Monoisotopic Mass	357.115g/mol
Rotatable Bond Count	7
Topological Polar Surface Area	96.8A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	3.1

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number